Association between PON1 L/M55 Polymorphism and plasma lipoproteins in two Canadian aboriginal populations

Clinical Chemistry and Laboratory Medicine

Volumn 38, Issue 5, 2000, Pages 413-420

  Fanella, S ^a   Stewart, B ^a   Harris, T ^a   Young, K ^a   Hanley, A J G ^a   Zinman, B ^a   Connelly, P W ^a   Hegele, R A ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Atherosclerosis; Metabolism; Oxidation; Polygenic disease

Indexed keywords

APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CANADA; CHOLESTEROL BLOOD LEVEL; CODON; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE DETECTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MARKER GENE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

EID: 0033880709     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2000.060     Document Type: Article

References (36)

1. Structural and functional diversity of paraoxonase
2. Paraoxonase genes and disease
3. Paraoxonase as a risk marker for cardiovascular disease: Facts and hypotheses
4. Human serum paraoxonase
5. Isolation and complete covalent structure of liver microsomal paraoxonase
6. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoproteins against low density lipoprotein oxidative modification
7. Paraoxonase and coronary heart disease
8. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo
9. Protective effect of high density lipoprotein associated paraoxonase; inhibition of the biological activity of minimally oxidized low density lipoprotein
10. The genetic basis of atherosclerosis
11. Gln-Arg 192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes
12. The molecular basis of the human serum paraoxonase activity polymorphism
13. Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease and myocardial infarction in type 2 diabetes
14. A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese
15. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM study
16. The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease
17. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes
18. Paraoxonase gene polymorphisms associated with coronary heart disease: Support for the oxidative damage hypothesis
19. Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism
20. The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese
21. Paraoxonase PON1 Polymorphism Leu-Met54 is associated with carotid atherosclerosis: Results of the Austrian stroke prevention study
22. Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: Prospective nested case-control study
23. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians
24. Are Canadian Inuit at increased genetic risk for coronary heart disease?
25. The prevalence of NIDDM and associated risk factors in native Canadians
26. The hepatocyte nuclear factor-1α G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree
27. Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations
28. Genetic variation in paraoxonase-2 is associated with variation in plasma lipoproteins in Canadian Oji-Cree
29. Linkage disequilibrium in finite populations
30. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
31. Killing the Shaman
32. Genetic markers in blood in a Canadian Eskimo population with a comparison of allele frequencies in circumpolar populations
33. The colonization of Beringia and the peopling of the New World
34. Cardiovascular diseases in a Canadian arctic population
35. Altered serum lipid profile after systemic infection in children: A risk factor for atherosclerosis?